Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-042310
Date:2022-07-15
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
Original Submission Date:

Reporting Person:

BOZILENKO MARINA
C/O ACELRX PHARMACEUTICALS, INC.
25821 INDUSTRIAL BLVD., SUITE 400 HAYWARD, CA 94545

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-07-15 A 15,500 a $0.00 40,500 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.2309 2022-07-15 deemed execution date A 31,000 (a) 2022-07-15 2032-07-14 common stock 31,000 $0.23 31,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
f2 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to reporting person's continuous service to the company.
f3 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to reporting person's continuous service to the company.
WhaleWisdom Logo

Elevate your investments